Ignite Creation Date:
2024-07-17 @ 11:04 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06494800
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-07-02
Brief Title:
Added Value of PETCT in Lung Cancer
Sponsor:
Sohag University
Organization:
Sohag University
Study Overview
Official Title:
Added Value of 18F-FDG PETCT in Lung Cancer
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Assess the value of PETCT in the diagnosis staging response evaluation and relapse monitoring of lung cancer
Detailed Description:
Lung cancer is a leading cause of cancer-related mortality worldwide accounted for 180 million deaths in 20201Egyptian statistics showed that lung cancer in men represents 82 of among all cancers of men according to the Egyptian National Cancer Program in 2014 3Epidemiological data indicate that the main risk factor for the development of lung cancer is cigarette smoking4Lung cancer is histologically divided into Non-small-cell lung cancer NSCLC which accounts for 85 of cases and Small cell lung cancer SCLC5Due to absence of screening most patients with lung cancer are not diagnosed until later stages when the prognosis is poor6Radiologic manifestations of bronchogenic carcinoma include obstructive pneumonitis or atelectasis lung nodule or mass apical mass cavitated mass or nodule or mass associated with lymphadenopathy6Conventional chest radiography computed tomography CT magnetic resonance imaging radionuclide scintigraphy and positron emission tomography PET all have been used for NSCLC staging7PETCT is a well-established radiological modality with high diagnostic accuracy in metastases detection compared to usual CT Also it has been reported that up to 10 of patients with bronchogenic carcinoma are found to have metastases on PETCT that were not detected on CT with subsequent different patients staging The high accuracy of PETCT in tumor staging makes it important for the treatment strategy of either surgical treatment radiotherapy or chemotherapy Also it becomes essential during the follow-up to detect recurrence PETCT shows a higher ability to evaluate the early response to the treatment as chemotherapy by its ability to detect the metabolic response even before the size change8The prognosis of lung tumors depends on early and accurate staging as well as the histopathological type of the primary tumor with the squamous cell carcinoma type regarded to be of a worse prognosis than that of adenocarcinoma9
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None